AGRX
Agile Therapeutics, Inc
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
26 hedge funds and large institutions have $28M invested in Agile Therapeutics, Inc in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
+1
Holders Change %
+4%
% of All Funds
0.56%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
7
Reduced
4
Closed
4
Calls
$386K
Puts
$2K
Net Calls
+$384K
Net Calls Change
+$297K
Top Buyers
| 1 |
PA
Perceptive Advisors
New York
|
+$12.7M |
| 2 |
Renaissance Technologies
New York
|
+$293K |
| 3 |
AG
Advisor Group
Phoenix,
Arizona
|
+$195K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$157K |
| 5 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$151K |
Top Sellers
| 1 |
FI
Fosun International
Hong Kong,
China
|
-$82.6K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$27.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$9K |
| 4 |
Morgan Stanley
New York
|
-$7K |
| 5 |
JGC
J. Goldman & Co
New York
|
-$6K |
